Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Fabrazzo

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorderPalmiero Monteleone, Michele Fabrazzo, Vassilis Martiadis, et al.
Journal of Clinical Psychopharmacology|July 3, 2004
Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary studyPalmiero Monteleone, Michele Fabrazzo, Mariangela Serra, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2009
Obsessive-compulsive disorder with poor insight: a three-year prospective studyFrancesco Catapano, Francesco Perris, Michele Fabrazzo, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|June 20, 2014
Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature reviewAlfonso Tortorella, Francesca Brambilla, Michele Fabrazzo, et al.
Frontiers in Psychiatry|July 3, 2019
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic StudyFrancesco Perris, Michele Fabrazzo, Valeria De Santis, et al.
Psychiatry Research|June 27, 2017
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasiasMichele Fabrazzo, Vincenzo Prisco, Gaia Sampogna, et al.
Clinical Schizophrenia & Related Psychoses|December 21, 2016
Brain Natriuretic Peptide as a Biomarker of Asymptomatic Clozapine-Related Heart Dysfunction: A Criterion for a More Cautious AdministrationVincenzo Prisco, Petrosino Monica, Germano Fiore, et al.
Journal of Affective Disorders|November 5, 2018
Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatmentsLuca Steardo, Michele Fabrazzo, Gaia Sampogna, et al.
Journal of Personalized Medicine|December 23, 2023
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological MechanismsMichele Fabrazzo, Salvatore Cipolla, Mariantonietta Pisaturo, et al.
Frontiers in Psychiatry|April 25, 2022
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case ReportsMichele Fabrazzo, Antonio Russo, Mario Luciano, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Endocrinology and Metabolism|November 7, 2003
Opposite changes in circulating adiponectin in women with bulimia nervosa or binge eating disorderPalmiero Monteleone, Michele Fabrazzo, Vassilis Martiadis, et al.
Journal of Clinical Psychopharmacology|July 3, 2004
Long-term treatment with clozapine does not affect morning circulating levels of allopregnanolone and THDOC in patients with schizophrenia: a preliminary studyPalmiero Monteleone, Michele Fabrazzo, Mariangela Serra, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 18, 2009
Obsessive-compulsive disorder with poor insight: a three-year prospective studyFrancesco Catapano, Francesco Perris, Michele Fabrazzo, et al.
European Eating Disorders Review : the Journal of the Eating Disorders Association|June 20, 2014
Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature reviewAlfonso Tortorella, Francesca Brambilla, Michele Fabrazzo, et al.
Frontiers in Psychiatry|July 3, 2019
Comorbidity of Obsessive-Compulsive Disorder and Schizotypal Personality Disorder: Clinical Response and Treatment Resistance to Pharmacotherapy in a 3-Year Follow-Up Naturalistic StudyFrancesco Perris, Michele Fabrazzo, Valeria De Santis, et al.
Psychiatry Research|June 27, 2017
Clozapine versus other antipsychotics during the first 18 weeks of treatment: A retrospective study on risk factor increase of blood dyscrasiasMichele Fabrazzo, Vincenzo Prisco, Gaia Sampogna, et al.
Clinical Schizophrenia & Related Psychoses|December 21, 2016
Brain Natriuretic Peptide as a Biomarker of Asymptomatic Clozapine-Related Heart Dysfunction: A Criterion for a More Cautious AdministrationVincenzo Prisco, Petrosino Monica, Germano Fiore, et al.
Journal of Affective Disorders|November 5, 2018
Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatmentsLuca Steardo, Michele Fabrazzo, Gaia Sampogna, et al.
Journal of Personalized Medicine|December 23, 2023
Bidirectional Relationship between HIV/HBV Infection and Comorbid Depression and/or Anxiety: A Systematic Review on Shared Biological MechanismsMichele Fabrazzo, Salvatore Cipolla, Mariantonietta Pisaturo, et al.
Frontiers in Psychiatry|April 25, 2022
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case ReportsMichele Fabrazzo, Antonio Russo, Mario Luciano, et al.
Pageof 5